Bayesian Capital Management, LP Geron Corp Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$1.76 - $6.38 $42,240 - $153,120
-24,000 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$3.29 - $4.82 $114,492 - $167,736
-34,800 Reduced 59.18%
24,000 $82,000
Q1 2018

May 15, 2018
BUY
$1.81 - $5.98 $106,428 - $351,624
58,800 New
58,800 $250,000

Others Institutions Holding GERN

# of Institutions
275
Shares Held
491M
Call Options Held
1.87M
Put Options Held
690K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email